Patients with cancer are presumed to be at increased risk of severe COVID-19 outcomes
due to underlying malignancy and treatment-induced immunosuppression. Of the first 178 …

Background The medium-term and long-term impact of COVID-19 in patients with cancer is
not yet known. In this study, we aimed to describe the prevalence of COVID-19 sequelae …

PURPOSE Variation in risk of adverse clinical outcomes in patients with cancer and COVID-
19 has been reported from relatively small cohorts. The NCATS'National COVID Cohort …

The SARS-Cov-2 pandemic in 2020 has caused oncology teams around the world to adapt
their practice in the aim of protecting patients. Early evidence from China indicated that …

We describe the outcomes in cancer patients during the initial outbreak of the COVID-19 in
Europe from the retrospective, multi-center observational OnCovid study. We identified 204 …

Importance Whether the severity and mortality of COVID-19 in patients with cancer have
improved in terms of disease management and capacity is yet to be defined. Objective To …

The SARS-CoV-2 pandemic significantly affected oncology practice across the globe. There
is uncertainty as to the contribution of patients' demographics and oncologic features to …

Simple Summary Cancer has been reported as a major risk factor for adverse outcomes and
death during COVID-19 pandemic. The aim of this study was to investigate the management …

ORIgINAl ARTIClE Wang, M. et al. KTE-X19 CAR T-cell therapy in relapsed or refractory
mantle-cell lymphoma. N. Engl. J. Med. 383, 1331–1342 (2020) 4.7% had severe clinical …

Abstract Background: The SARS-CoV-2 outbreak in Paris' region significantly affected
Gustave Roussy cancer center. Here, we report the Gustave Roussy experience during the …